Neuroprotective strategies to avert seizure-induced neurodegeneration in epilepsy

Janice R Naegele1

  • 1Department of Biology, Room 257, Hall-Atwater Laboratory, Lawn Avenue, Wesleyan University, Middletown, CT 06459, USA. janaegele@wesleyan.edu

Epilepsia
|June 16, 2007
PubMed

Insights

Chronic temporal lobe epilepsy (TLE) involves limbic circuit neurodegeneration. Inhibiting active cell death reduces injury but doesn't stop seizure generation, highlighting the need for further research into TLE mechanisms.

Area of Science:

  • Neuroscience
  • Epilepsy Research
  • Cell Biology

Background:

  • Neurodegeneration in limbic circuits is characteristic of chronic temporal lobe epilepsy (TLE).
  • Seizure-induced neuronal injury involves both active and passive cell death pathways.
  • Existing research shows inhibiting active cell death reduces neuronal damage but not epileptogenesis.

Purpose of the Study:

  • To investigate the pathological mechanisms underlying seizure generation in TLE.
  • To explore the therapeutic potential of inhibiting cell death in seizure disorders.
  • To compare findings from animal models and human patient brain slices.

Main Methods:

  • Utilizing experimental animal models of TLE.
  • Analyzing brain slices from human patients with TLE.
  • Employing experimental approaches to inhibit active cell death pathways.

Main Results:

  • Inhibition of active cell death processes reduced neuronal cell death and sclerosis in TLE models.
  • Inhibiting active cell death did not prevent epileptogenesis in animal models of TLE.

Conclusions:

  • Neuronal cell death inhibition is not sufficient to prevent epileptogenesis in TLE.
  • Further research is needed to understand seizure generation mechanisms in TLE.
  • Comparative studies using animal models and human brain tissue are crucial for evaluating cell death inhibition therapies.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...